Objectives

The main goal of the ToxoReTREAT project is to solve the problem of reactivated toxoplasmosis (RT) in the population of allogeneic hematopoietic stem cells transplant recipients by applying a multidisciplinary approach (medicine, pharmaceutical chemistry, computer science) to offer cost-benefit improvements in the management of RT and efficient novel treatment options.